Abstract: Electroconvulsive therapy (ECT) is still the most effective treatment not only for psychotic depression, but also for treatment of resistant or other severe forms of major depressive episodes. Nevertheless, the exact nature of the therapeutic effect of ECT is unknown. Modern theories of depression suggest changes of synaptic plasticity especially within the hippocampus. It was hypothesized that such changes may be reflected in changes of proton magnetic resonance spectroscopy ( 1 H MRS) detectable signals.
INTRODUCTION
Electroconvulsive therapy (ECT) is still the most effective treatment not only for psychotic depression, but also for treatment of resistant or other severe forms of major depressive episodes [1, 2] . Compared to modern antidepressive drug treatment side effects are less in extent and usually limited to short term memory problems. The exact nature of the therapeutic effect of ECT is unknown. Early studies suggest that the induced seizures and not the current itself act as the therapeutic agent since drug induced seizures (like i. v. pentylenetetrazole or inhalation of flurothyl) have comparable efficacy [3] .
Nowadays it is hypothesized that the manifold mechanisms of antidepressive action follow a final common pathway, i.e. a final induction of specific alterations of neuroadaptation in specific brain regions [4] . In such a modern disease model behavioral depressive changes relate in part to alterations in hippocampal function. These are thought to be induced through activation of Cyclic AMP Response Element-Binding protein (CREB) and neurotrophins such as Brain Derived Neurotrophic Factor (BDNF) [5] . In rats treated with electroconvulsive shocks (ECS), an animal model of ECT, changes in hippocampal neurotrophin and gene expression were detected [6] [7] [8] . Furthermore, the induction of mossy fiber sprouting by ECS has been demonstrated on a cellular level [9] . Additionally, recent findings point towards a sprouting of serotonergic axons in the hippocampus after ECS [4, 6, 10, 11] .
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Structural brain imaging studies, post mortem examinations, CSF investigations and animal models did not provide any evidence for an ECT associated structural brain damage [12, 13] .
In looking further for biochemical changes magnetic resonance spectroscopy (MRS) studies offer a considerably more sensitive method than structural imaging investigations. MRS allows quantitative and non-invasive access to a number of biochemical constituents in different brain regions. Several MRS studies have shown regional metabolic alterations in patients suffering from major depressive episodes either in unipolar or bipolar affective disorders [14] .
There are multiple reasons for a rising interest in combining ECT as the treatment of choice and MRS as a subtle monitoring tool for metabolic changes that might be associated with therapeutic efficacy in depression.
In looking for very small detectable signal changes in disorders with unknown etiology, the chances for detecting a significant change are maximized if severely ill patients are investigated using the most effective method of treatment and non-invasive measurements with high enough sensitivity that can be repeatedly conducted enabling longitudinal monitoring of treatment effects. Another reason may be that antidepressants and ECT represent different treatment regimes which probably share a final common pathway i. e. a final induction of specific alterations of neuroadaptation in specific brain regions [4] . Comparing them via M R S monitoring allows a better differentiation between treatment induced changes and those that are attributable to the disorder itself.
ECT and MRS are transferable into animal models. This is a great advantage since MRS is the only non-invasive tool monitoring metabolic changes in patients in vivo. Most of our knowledge about etiopathogenesis of depression comes from animal models, and MRS may be the tool of choice to bridge the gap between clinical and preclinical research in psychiatric disorders. Magnetic resonance spectroscopy has become a complex and sophisticated neuroimaging technique that enables reliable and reproducible quantification of an increasing number of neurometabolites.
Since metabolite concentrations are more than 10 3 times smaller than the tissue water concentration spatial and temporal resolution is low for in vivo MRS applications. All but two studies applying 1 H MRS to study the effects of ECT on brain metabolism used single voxel techniques i. e. acquired a single spectrum from a certain brain region [15] [16] [17] [18] [19] [20] . The only 1 H MR spectroscopic imaging studies to date of patients undergoing ECT are our own studies: The chosen spectroscopic slice was only further restricted by an additional volume pre-selection limiting the observed voxels to both hippocampi and the brain stem [21, 22] (see Fig. 1 ). Fig. (1) . Sagittal, transverse and coronal MR slices with MRS volume of interest (VOI) outlines from the reviewed MRS studies. Outlines have been estimated from the VOI sizes and positions described in the original references. Red squares: approximate single voxel position for spectra acquired from a central brain location by Wood et al. [15] , 100 ml VOI size. Blue square: approximate single voxel position for spectra acquired from a central brain location by Felber et al. [16] , 64 ml VOI size. White squares: PRESS box volume and selected hippocampal voxels from the MRSI studies of the hippocampal region by Ende et al. [21] and Obergriesser et al. [22] , both 2.4 ml effective VOI size. Yellow squares: approximate single voxel position for spectra acquired from the amygdala by Michael et al. [19] , 3.375 ml VOI size. Pink squares: approximate single voxel position for spectra acquired from the left anterior cingulate gyrus by Pfleiderer et al. [17] , 3.375 ml VOI size. Light blue square: approximate single voxel position for spectra acquired from left DLPFC by Michael et al. [18] , 3.375 ml VOI size. Orange square: approximate single voxel position for spectra acquired from the occipital cortex using a surface coil positioned on the midline by Sanacora et al. [20] , 13.5 ml VOI.
This review is not focused on technical aspects of MR sequences and their sensitivity to metabolite resonances.
There are hundreds of metabolites produced by the human brain, but only some can reliably be detected and quantified using 1 H MRS. The significant neurometabolites that have been measured in patients with major depression following ECT treatment are: Glutamate, glutamine andaminobutyric acid (GABA), N-Acetylaspartate (NAA), choline-containing compounds (Cho), creatine and phosphocreatine (tCr), lactate (LAC) and lipids.
Myo-inositol (mI) has been quantified in some studies investigating depressed patients and findings are heterogeneous [23] . The specific importance of mI is based on the fact that its lipid conjugates are directly involved into the inositol-3-phosphate (IP3) second messenger pathway. The "inositol depletion hypothesis" explains the mechanism of action of lithium in bipolar disorders [24] . Unfortunately, to our knowledge there are no spectroscopic data of mI changes after electroconvulsive therapy, neither in patients nor in animals.
Glutamate, Glutamine and -Aminobutyric Acid (GABA)
Glutamate is the major excitatory, and GABA the major inhibitory neurotransmitter in the human brain. Both glutamate and GABA are linked to metabolism through a neurotransmitter cycle between neurons and glia. In this cycle neurotransmitter molecules released by the neurons are taken up by transporters in surrounding glial cells. In the glia they are converted to glutamine which is released to the neuron where it is used for resynthesis of the neurotransmitter.
Glutamate is present at an even higher concentration as NAA in the brain, though in practice glutamate, glutamine and GABA signals are barely detectable using clinical MR scanner at 1.5 T. The MR sensitivity for their detection is poor due to their signal intensity being spread over a large number of closely spaced multiplett resonances and from signal cancellation of overlapping resonances due to phase differences at longer echo times.
In order to detect these resonances at 1.5 T short echo times under 30 ms have to be employed. As a rule spectra acquired at short TE have an increased signal to noise ratio compared to longer echo time spectra and may allow for the quantification of a variety of overlapping signals. At a field strength of 1.5 T attempts have been made to quantify the overlapping signals of glutamate, glutamine and GABA at the 2.3 ppm position, labeled as Glx. The origin of the glutamate signal (e. g. intra versus extra cellular) in 1 H MRS brain spectra can not be sub-classified. All mobile molecules will contribute equally to the observed glutamate resonance. An example for a spectrum acquired at 1.5 T with the (relative) short TE of 30 ms is shown in Fig. 2.   Fig. (2) . Example for a short TE (30 ms) 1 H spectrum of the human hippocampus obtained with a PRESS sequence (TR = 2 s, number of acquisitions = 128) at 1.5 Tesla from a 17.5 ml VOI.
GABA is synthesized primarily from the glutamate precursor in GABAergic neurons. About 15% of the brain energy consumption is GABA-related [25] . The in vivo detection of GABA via 1 H MRS requires special editing methods that have been pioneered by Rothman and colleagues from Yale [26] .
Human Studies
Glx (Glutamate, Glutamine)
As explained above, glutamate, glutamine and GABA are hard to discriminate in 1 H MRS. For most cases and especially for brain tissue, GABA contributions at the evaluated peak position at 2.3 ppm can be neglected since brain tissue concentrations are about one magnitude lower (12 -14 mmol/kg compared to 1 mmol/kg). Three studies focusing on Glx changes were conducted by Pfleiderer and Michael et al. [17] [18] [19] . In two studies with 12 and 17 patients with a major depressive episode (7 patients were overlapping) they describe a significant increase of cortical Glx in the left dorsolateral prefrontal cortex (DLPFC) and in the left anterior cingulum (AC). Glx levels were lower compared to normal controls before treatment and normalized after a successful ECT course (see Fig. 1 for MRS voxel position). Glx levels of non responding patients remained unchanged (AC and DLPFC). Pfleiderer and Michael hypothesize that Glx deficits may reflect a neuronal/glial functional deficit. Michael postulates Glx as a state marker for depressive syndromes since it was found to correlate with the state of a major depressive episode and response to treatment and cites DLPFC Glx dysfunction as a marker of depressed mood and psychomotoric retardation.
In a preceding study of Auer et al. [27] Glx and resolved Glu was found to be reduced in 19 depressed patients in the anterior cingulate. Friedman et al. described a Glx decrease in lithium (n = 12) or valproic acid (n = 9) treatment in bipolar disorder patients (in remission) in a recent cross examination study. This decrease in the left anterior cingulate gray matter fraction was lithium level dependent at a trend level [28] .
In a third study Michael and Pfleiderer [19] detected a Glx increase after an ECT course in a voxel containing the left amygdala region and the anterior third of the hippocampus. Successful ECT caused a normalization of Glx levels regardless of unipolar (n = 13) or bipolar depression (n = 15).
Discussion Glx
The three studies of Michael et al. and Pfleiderer et al. showed a below-normal Glx in depressed patients in all three investigated regions: left DLPFC, left AC and left amygdala region including the anterior part of the hippocampus. All Glx levels normalized with successful ECT. Hypofunction of the glutamatergic system or general hypometabolism may lead to such an unspecific Glx change. Whether Glx in those key regions has the power to be a candidate as a state marker has to be proven. The influence of lorazepam has to be quantified. In the cited studies patients received up to 3 mg/d lorazepam, enough to have a measurable clinical impact which also could influence MRS detectable Glx, especially if it was a state marker. A cortical glutamatergic change induced by a GABAergic substance in severe depression would also be plausible.
GABA (Gamma-Aminobutyric Acid)
Following existing data that GABA levels in plasma and CSF of depressed patients are reduced, and that ECT has not only an antidepressive but an anticonvulsive effect Sanacora et al. [20] hypothesized an elevation of GABAergic neurotransmission during an ECT course. They quantified GABA in an occipital voxel using a spectral editing method established by Rothman et al. [26] . In altogether 7 MDD patients GABA rose from 0.85 mmol/kg to 1.51 mmol/kg post ECT. There was no correlation to remission of depressive symptoms nor to memory deterioration but statistics is hampered by the small sample size. Since serotonine re-uptake inhibitors as antidepressive therapy also lead to an increase of occipital cortical GABA concentration Sanacora argued that this alteration could reflect antidepressive action and not changes of convulsive susceptibility [29] . This interpretation was relativized by Bhagwagar et al. [30] who administered an i. v. SSRI to healthy volunteers and replicated an occipital increase of GABA applying another GABA editing method published by Keltner et al. [31] . The authors interpreted the GABA increase as an SSRI effect independent of clinical changes in mood and independent of an antidepressive effect.
Discussion GABA
GABA agonists are effective as antidepressants in patients as well as in animal models [32] , and patient as well as animal data suggest an important role in distinct brain regions [33] .
To our knowledge there is only one study using ECT as a treatment tool [20] . The three cited studies detecting GABA in the human brain [20, 29, 30] used two different editing techniques quantifying GABA concentrations in one large occipital voxel. An elevation of GABA was inducible via ECT and SSRI medication, but the latter was also seen in healthy volunteers. So it remained unclear if the GABA increase is an unspecific treatment effect in the occipital cortex.
N-Acetylaspartate (NAA)
Found solely in the brain, NAA is present in both gray and white matter and is considered a marker of neuronal and axonal integrity. The NAA resonance is typically the tallest peak in the normal brain spectrum. Since its decrease or disappearance can be due to either cell death or axonal injury, it is considered to be a measure of neural tissue viability and/or function.
Human Studies
NAA was identified as a neuronal marker in early histological studies [34] and as a marker of neuronal functioning. The latter was most imposingly demonstrated in longitudinal studies in Alzheimer's disease (AD) [35, 36] . In MRS studies of major depression treated with ECT hippocampal, DLPFC, AC and amygdala regions were investigated for changes of NAA.
In an own study we postulated a hippocampal NAA decrease underlying the intermittent cognitive side effects of ECT. This hypothesis could not be confirmed. If at all NAA showed a trend toward an increase post ECT. A follow-up study after 12 to 32 months including 12 of the initial 17 patients demonstrated an identical NAA level compared with pre ECT values. The group of Michael and Pfleiderer discovered a left hemispherical reduction of NAA in amygdala regions, but not in DLPFC and AC [17] [18] [19] . However, DLPFC levels were inversely correlated to duration and severity of illness in depressed patients. Additionally, an increase of NAA was only seen in ECTresponders in the amygdala by Michael et al. who postulate NAA as a neurotrophic antidepressive factor.
Further studies support the view of illness related NAA/tCr loss in the hippocampus [37] and in DLPFC [38] . Blasi et al. found in 17 patients with a first mood disorder episode with psychotic symptoms (7 mania, 10 MDE) a significant reduction of NAA/tCr within the hippocampus as compared to healthy controls. Winsberg et al. showed in 20 bipolar I and II patients a NAA/tCr reduction in the DLPFC. The latter was not replicated in the study of Blasi who also investigated several additional brain regions including the dorsolateral prefrontal cortex. In this study [35] only the above mentioned hippocampal findings survived an overall statistical correction. Deicken et al. also saw a hippocampal NAA loss in 15 bipolar I patients in remission state [39] .
Animals
To our knowledge, there is only one animal study combining an animal model of depression, ECT and MRS: Learned Helplessness is an animal model of depression based on the hypothesis that depression is induced by uncontrollable stress in individuals with a predisposition. We established this model in Sprague-Dawley rats and used a strictly elaborated protocol defining some rats as being "learned helpless" (LH) or "not learned helpless" (NLH) [40] . Using a 4.7 T animal scanner we were able to scan a single voxel (~ 10 μl) within the dorsal rat hippocampus. After a 6 day electroconvulsive shock (ECS) course, Cho/NAA increased in all animals and additionally tCr/NAA also increased in LH animals [41] . NAA was not absolutely quantified. By using it as a gauge control, an increase of ratios caused by a decrease of NAA cannot be completely ruled out.
Czeh et al. found in another high validity animal model of depression similar results: They investigated tupaia belangeri (tree shrews) in a chronic psychosocial stress model. In this model after a single social confrontation with a dominant male, a subordinate second animal experiences chronic psychological stress just in visual presence of the dominant one. Czeh et al. used this paradigm to look for changes in a region including forebrain and hippocampus of the tupaia. Under such a chronic stress condition NAA decreased, which was preventable by tianeptine [42] and in a latter study also by clomipramine and by L-760.735, a NK(1)-receptor antagonist [43] .
Discussion NAA
Hippocampal NAA levels have been hypothesized to be affected by depression [4, 44] . Modern theories suggest that hippocampal changes in neurogenesis and/or synaptogenesis rates should be reflected in detectable NAA changes. Taking all afore said together, including the animal model of chronic psychosocial stress it seems that such a NAA loss is likely but small and hence hard to quantify. It is possible that due to the low statistical power NAA differences between MDD patients and controls were not detected in our studies [21, 22] .
Lack or reduction of neurogenesis or synaptogenesis must not necessarily be reversible by antidepressive treatment. Hippocampus [45] or prefrontal cortex [46] volume loss in chronic MDD patients as well as the data of Michael et al. [18] support a lasting volume reduction. DLPFC NAA was negatively correlated to severity and duration of illness but not to treatment success [18] and NAA was significantly elevated in ECT responders in the amygdala [19] . Additionally, the potency of synaptogenesis may be region dependent, and at least for neurogenesis it only is seen in the hippocampus. Altogether, with refined MRS methods (i. e. higher field strength, coil and sequence improvements) and larger patient cohorts a NAA rise could turn out to be a treatment independent (ECT vs. drugs) neurotrophic and antidepressive marker.
Choline-Containing Compounds (CHO)
The MR detectable Cho signal represents the trimethyl ammonium resonance of a variety of choline-containing compounds. The MRS resonance is composed of acetylcholine (ACh), phosphocholine (PC), glycerophosphocholine (GPC), and free choline. Most of the signal arises from PC and GPC, free choline is less than 5 % and the contribution from ACh is negligible [47] . An increased Cho signal most likely reflects an increase in membrane turnover.
Phosphatidylcholine, the major choline-containing metabolite of the normal brain, is MR-invisible in myelin, cell membranes, and other brain lipids under normal circumstances. However, under certain conditions visible choline may be released from this pool [48] . In proton MR spectroscopy (non membrane bound) phosphocholine and glycerophosphocholine can not be distinguished -both are detected within one choline peak.
Human Studies
In our study we were able to identify a significant belownormal hippocampal choline in MDE patients [21] . This signal increased significantly and even individually (in 17 of 18 patients) during an ECT course. After a follow-up period of 20 month Cho fell back to pre ECT levels [22] . Three spectra pre, one day post ECT and 12 months post ECT (follow-up) from a patient included in this study are shown in Fig. 3 . It has been concluded that low hippocampal Cho marks a depressive trait. This would include an unspecific and short termed peak in the phase of remission. Maybe lower Cho anticipates a relapse condition. In our study two of the twelve follow-up patients were in the state of relapse.
Michael et al. found a trend toward a below-normal Cho in MDE patients in voxels including about 1/3 of the anterior hippocampus and the amygdala [19] .
To our knowledge there are no further studies in MDE patients investigating hippocampal and amygdala tissue.
This may be due to susceptibility artifacts, shimming difficulties and other pitfalls in this etiopathogenetically highly important region.
Two studies investigating hippocampal tissue via proton MRS in bipolar disorder (in remission) found no evidence for alterations in Cho [39, 49] . There are not many data for the AC. Michael et al. found Cho levels to be unchanged by ECT and a trend towards lower levels in depressed patients compared to controls. In a study of bipolar patients in the depressed state Moore et al. showed a positive correlation between severity of depression and Cho/tCr ratios [51] .
Animals
Both above mentioned animal models (Learned Helplessness and Chronic Psychosocial Stress) found a significant choline rise in treated animals. In our study the rise in Cho/NAA and Cho/tCr within the dorsal hippocampus following ECT was unspecific to the model [52] . Czeh et al. found in frontal brain regions including the rostral part of the hippocampus that Cho levels are decreased by stress [42] .
Discussion Cho
Since phospholipases, which are also responsible for neurotransmitter release and membrane turnover, are involved in phosphocholine and glycerophosphocholine production Cho changes could be interpreted as a marker of new or increased synaptic plasticity.
For the first time it was possible to bridge between clinical and preclinical studies in this context by transferring hippocampal MRS into an animal model and to identify herein that hippocampal choline rise can be purely induced via ECT [21, 52] . However, hippocampal Cho is reduced in depressed patients [21] and in animals suffering from chronic psychosocial stress [42] . As an interpretation higher membrane turnover does not necessarily mean higher synaptic plasticity. The fact that NAA changes are not detectable could simply reflect that membrane turnover might exhibit a different time dependence than NAA changes. The hippocampal choline time course after ECT seems to be short termed [22] . With this hypothesis it remains hard to explain, why in the study of Michael NAA increased significantly, but Cho did not. A more pronounced Cho increase in the hippocampus versus the amygdala could be explained with the assumption that the induced seizures would affect the hippocampus more than the amygdala.
Creatine and Phosphocreatine (TCR)
In normal brain metabolism, phosphocreatine supplies phosphate to adenosine diphosphate (ADP), resulting in the production of an adenosine triphosphate (ATP) molecule and the release of creatine. Thus, total creatine (creatine plus phosphocreatine, tCr) should be a reliable marker of brain metabolism. Creatine, phosphocreatine, and their main precursor, guanidinoacetate, are synthesized in extracerebral tissues (primarily liver and kidney) and then transported to the brain. Therefore, any metabolic defect resulting in decreased production of creatine/phosphocreatine (e.g. hepatic or renal diseases) will lower the tCr peak.
The tCr signal has been used for gauging in metabolite ratios like NAA/tCr in countless studies. However, tCr represents an important buffer capacity in the energy metabolism of the cell which can not be considered 100 % stable a priory. Recent studies show a brain activity dependent change in tCr signal intensity [53] . That tCr is not always useful as a reference compound has already been suggested more than a decade ago [54] .
Human Studies
Some findings support significant changes of brain tCr. Michael et al. observed in the DLPFC study a negative correlation between tCr levels and the Montgomery-Asberg rating scale (MADRS) pre ECT. Pettegrew et al. used 31 P spectroscopy in two patients and found a Hamilton depression rating scale (HDRS) dependent frontal Phosphocreatine (PCr) loss [55] . In the above mentioned study of Kumar et al. [50] tCr levels of the DLPFC were not significantly lower but showed a trend towards reduction. Cho levels also were not significant different from control Cho levels but Cho/tCr was significantly higher in patients. This might actually be a good example that tCr reflects more than a reference.
Hippocampal tCr seems to be affected by depression and ECT. In our ECT study tCr increased significantly intraindividually in the patients during ECT although neither level reached significance in comparison to controls [21] . A similar observation was made by Michael et al. [19] , where tCr levels in the amygdala region including the anterior 1/3 of the hippocampus in responders showed a trend towards an increase.
Animals
In both of the above discussed animal models (Learned Helplessness and Chronic Psychosocial Stress) a significant rise of tCr in treated animals was detected. In our study the NAA/tCr rise within the dorsal hippocampus was specific to animals characterized as Learned Helpless [41] . In the Chronic Psychosocial Stress model tCr in frontal brain regions including the rostral part of the hippocampus increases with treatment [42, 43] .
Discussion tCr
Creatine and phosphocreatine represent the main energy buffer system sustaining ATP in the cell. Changes in tCr levels therefore may reflect disturbances in mitochondrial function [56] or in tCr production or transport. Furthermore, there is recent evidence for a changed brain energetic pattern in depression, which are consistent across 31 P MRS, PET and DNA microarray studies [57] [58] [59] .
In most of the above cited studies tCr was lowered in hippocampal and prefrontal regions in depression. Within those regions tianeptine and ECS were able to augment tCr in two different animal models of depression. This suggests a connection between hippocampal and prefrontal tCr levels and MDD as a reflection of alterations in energy metabolism [41] .
Lactate (LAC)
If oxygen supplies are depleted, the brain switches to anaerobic glycolysis. Lactate production is one end product of this metabolic pathway. Therefore, the presence of a lactate doublet in a proton MR spectrum is a sign of hypoxic tissue. The etiology of decreased oxygen supply may include: decreased oxygen delivery, increased oxygen demand, or a combination of the two.
Human Studies
The first three 1 H MRS studies in patients undergoing ECT reported pre and post ECT spectra obtained with single voxel MRS techniques from a central brain volume [15, 16, 60] . Those initial studies were aimed at lactate detection following ECT. All studies failed to detect lactate.
Discussion
There is no evidence for hypoxic conditions indicated by lactate changes caused by ECT.
Lipids
Lipids are found generally in the form of fatty acids, triglycerides, and phospholipids incorporated into cell membranes and myelins. They are not generally detectable on 1 H MRS until released by destructive processes of the brain including necrosis, inflammation, or infection. In order to exclude contributions from extracerebral sources of lipids care must be taken when selecting the volume to be studied.
Human Studies
Woods and Chiu [60] reported elevated lipid signal levels following ECT using a single voxel MRS method with a short echo time and a huge 5 x 5 x 4 cm 3 voxel centered in mid brain including the ventricles. They postulated that a significant portion of this lipid signal is related to maximal activation of the phosphatidylinositol system (increased levels of diacylglycerol and free fatty acids) having generalized inhibitory effects potentially relevant to both the clinical pathophysiology of seizures and the efficacy of ECT in major affective disorders. Chiu and Woods related later electrical current flux densities to their results [61] and their finding up to date has not been replicated by the other groups applying short echo time MRS to study ECT induced brain changes.
Discussion
The general impact of the phosphatidylinositol system on depression theories (e.g. "inositol depletion") has been described above. Yet, the first findings of lipid signal increases following ECT have not been replicated by the later MRS studies of ECT induced spectral changes.
CONCLUSIONS
MRS potentially is a tool which allows a direct test of theories concerning the pathophysiology of depression. Features favoring this method include its non-invasiveness, its accuracy, and its specificity. Since most of the fundamental knowledge about psychiatric illnesses comes from animal models, this knowledge has to be transferred from pre-clinic to clinic and vice versa. Again MRS seems to be one of the rare instruments which are able to bridge such a wide gap. ECT is still the method of choice in treating severe forms of depression. To date there only exist a few studies attempting to put those pieces together [17] [18] [19] 21, 41] . Nevertheless, it is impressive what has been tested concerning modern theories of depression. There is evidence that NAA as a marker of neuronal viability and probably of synaptic plasticity is impaired in hippocampal and prefrontal regions in depression and its animal model. Choline, representing membrane turnover and supposable changes in synaptic plasticity seems to be impaired in hippocampal and prefrontal regions in MDD patients as well as in animal models of depression. Furthermore, at least in the animal models tCr seems to mirror energy metabolism hypofunction within the same regions and state.
Early human and animal studies identified ECT induced changes in T1 and T2 H 2 O relaxation times within human thalamus and cerebrum [62] [63] [64] as well as in rat cortex [65] . Those changes potentially effect metabolite quantification but have been described as short termed ( hours). To our knowledge there are no studies monitoring metabolite relaxation time changes induced by ECT.
The MRS studies in humans or animals have to be replicated, extended and corroborated to strengthen the support for the underlying theories and their fundamental meaning. Both larger patient cohorts and refined MRS methods at higher field strength will improve our understanding of the underlying mechanisms for the efficacy of ECT for the treatment of major depression.
